Preferred Pharmaceuticals, Inc. recalls Clindamycin Hydrochloride Capsules
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- cGMP Deviations
- Products
-
- Clindamycin Hydrochloride Capsules
- Where it was sold
-
Nationwide in the US
Nationwide
- Units affected
- 1190 Bottles
- About this recall
- Clindamycin Hydrochloride Capsules, USP, 300mg, 30-count bottles, Manufactured by: Glenmark Pharmaceuticals Limited, NDC 68788-8685-03.